Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yannick Allanore

Showing results (401-410 of 448) with videos related to

Pageof 45
Sort By:
Rheumatology (Oxford, England)|March 9, 2024
Biomarker analysis from the phase 2b randomized placebo-controlled trial of riociguat in early diffuse cutaneous systemic sclerosisDinesh Khanna, Frank Kramer, Josef Höfler, et al.
Annals of the Rheumatic Diseases|May 30, 2026
Novel HLA class I and II insights into the pathogenesis of systemic sclerosis-associated interstitial lung diseaseCarlos Rosa-Baez, Carlos Rangel-Peláez, Inmaculada Rodriguez-Martin, et al.
Seminars in Arthritis and Rheumatism|October 1, 2011
"To be or not to be," ten years after: evidence for mixed connective tissue disease as a distinct entitySusanna Cappelli, Silvia Bellando Randone, Dušanka Martinović, et al.
RMD Open|June 9, 2026
Safety and effectiveness of tocilizumab in systemic sclerosis: a multicentre French-Italian studyGiulia Buonsante, Giacomo De Luca, Elena Marazzi, et al.
Arthritis Care & Research|June 15, 2026
Real-World Safety and Effectiveness of JAK Inhibitors in Systemic Sclerosis: A Propensity-Matched Study from the EUSTAR CohortStefano Di Donato, Marie-Elise Truchetet, Marco Minerba, et al.
Orphanet Journal of Rare Diseases|July 26, 2021
French recommendations for the management of systemic sclerosisEric Hachulla, Christian Agard, Yannick Allanore, et al.
Journal of Scleroderma and Related Disorders|September 25, 2023
Systemic sclerosis and primary biliary cholangitis: Longitudinal data to determine the outcomesGemma Lepri, Paolo Airò, Oliver Distler, et al.
The European Respiratory Journal|September 4, 2025
ERS/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung diseaseDeveloped by the task force for connective tissue disease-associated interstitial lung disease of the European Respiratory Society (ERS) and the European Alliance of Associations for Rheumatology (EULAR)Endorsed by the European Reference Network on rare respiratory diseases (ERN-LUNG)Katerina M Antoniou, Oliver Distler, Ana-Maria Gheorghiu, et al.
Annals of the Rheumatic Diseases|September 5, 2025
ERS/EULAR clinical practice guidelines for connective tissue diseases associated interstitial lung diseaseKaterina M Antoniou, Oliver Distler, Ana-Maria Gheorghiu, et al.
Journal of Clinical Epidemiology|April 12, 2014
Multicriteria decision analysis methods with 1000Minds for developing systemic sclerosis classification criteriaSindhu R Johnson, Raymond P Naden, Jaap Fransen, et al.
Pageof 45

Showing results (401-410 of 448) with videos related to

Sort By:
Pageof 45
Rheumatology (Oxford, England)|March 9, 2024
Biomarker analysis from the phase 2b randomized placebo-controlled trial of riociguat in early diffuse cutaneous systemic sclerosisDinesh Khanna, Frank Kramer, Josef Höfler, et al.
Annals of the Rheumatic Diseases|May 30, 2026
Novel HLA class I and II insights into the pathogenesis of systemic sclerosis-associated interstitial lung diseaseCarlos Rosa-Baez, Carlos Rangel-Peláez, Inmaculada Rodriguez-Martin, et al.
Seminars in Arthritis and Rheumatism|October 1, 2011
"To be or not to be," ten years after: evidence for mixed connective tissue disease as a distinct entitySusanna Cappelli, Silvia Bellando Randone, Dušanka Martinović, et al.
RMD Open|June 9, 2026
Safety and effectiveness of tocilizumab in systemic sclerosis: a multicentre French-Italian studyGiulia Buonsante, Giacomo De Luca, Elena Marazzi, et al.
Arthritis Care & Research|June 15, 2026
Real-World Safety and Effectiveness of JAK Inhibitors in Systemic Sclerosis: A Propensity-Matched Study from the EUSTAR CohortStefano Di Donato, Marie-Elise Truchetet, Marco Minerba, et al.
Orphanet Journal of Rare Diseases|July 26, 2021
French recommendations for the management of systemic sclerosisEric Hachulla, Christian Agard, Yannick Allanore, et al.
Journal of Scleroderma and Related Disorders|September 25, 2023
Systemic sclerosis and primary biliary cholangitis: Longitudinal data to determine the outcomesGemma Lepri, Paolo Airò, Oliver Distler, et al.
The European Respiratory Journal|September 4, 2025
ERS/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung diseaseDeveloped by the task force for connective tissue disease-associated interstitial lung disease of the European Respiratory Society (ERS) and the European Alliance of Associations for Rheumatology (EULAR)Endorsed by the European Reference Network on rare respiratory diseases (ERN-LUNG)Katerina M Antoniou, Oliver Distler, Ana-Maria Gheorghiu, et al.
Annals of the Rheumatic Diseases|September 5, 2025
ERS/EULAR clinical practice guidelines for connective tissue diseases associated interstitial lung diseaseKaterina M Antoniou, Oliver Distler, Ana-Maria Gheorghiu, et al.
Journal of Clinical Epidemiology|April 12, 2014
Multicriteria decision analysis methods with 1000Minds for developing systemic sclerosis classification criteriaSindhu R Johnson, Raymond P Naden, Jaap Fransen, et al.
Pageof 45